Stock Analysis
- France
- /
- Life Sciences
- /
- ENXTPA:ERF
Eurofins Scientific's (EPA:ERF) Earnings May Just Be The Starting Point
When companies post strong earnings, the stock generally performs well, just like Eurofins Scientific SE's (EPA:ERF) stock has recently. Our analysis found some more factors that we think are good for shareholders.
See our latest analysis for Eurofins Scientific
How Do Unusual Items Influence Profit?
Importantly, our data indicates that Eurofins Scientific's profit was reduced by €133m, due to unusual items, over the last year. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. If Eurofins Scientific doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Eurofins Scientific's Profit Performance
Because unusual items detracted from Eurofins Scientific's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think Eurofins Scientific's earnings potential is at least as good as it seems, and maybe even better! And on top of that, its earnings per share increased by 40% in the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. If you want to do dive deeper into Eurofins Scientific, you'd also look into what risks it is currently facing. For example - Eurofins Scientific has 1 warning sign we think you should be aware of.
This note has only looked at a single factor that sheds light on the nature of Eurofins Scientific's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
Valuation is complex, but we're here to simplify it.
Discover if Eurofins Scientific might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ENXTPA:ERF
Eurofins Scientific
Provides various analytical testing and laboratory services worldwide.